<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="995">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00382707</url>
  </required_header>
  <id_info>
    <org_study_id>3540</org_study_id>
    <nct_id>NCT00382707</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.</brief_title>
  <official_title>Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epileptic disease is characterised by enhanced brain excitability. Low frequency repetitive
      transcranial magnetic stimulation (rTMS) can be an effective treatment for refractory
      frontal epilepsy. Thought, physiological mechanisms of its effectivity are still unknown. It
      is yet possible to evaluate cortical excitability and inhibition with TMS-coupled
      electromyography before and after rTMS sessions ; this could provide clues for basic
      mechanisms of rTMS effects on the epileptic brain. We assume that rTMS decrease brain
      excitability by improving brain inhibition. Such an information could help for treating
      patients with both pharmacological and non-pharmacological methods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Electrophysiological parameters for cortical excitability measured just before and after rTMS, 4 hours later and 24 hours later.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical efficacity on seizure intensity and frequency.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Refractory Frontal Lobe Epilepsy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cortical magnetic stimulation provided by an eight-shaped coïl placed upon the skull.</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cryptogenic frontal lobe epilepsy

          -  Normal cerebral MRI
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge CHASSAGNON, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Département de Neurologie - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Physique Biologique</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <lastchanged_date>August 29, 2011</lastchanged_date>
  <firstreceived_date>September 28, 2006</firstreceived_date>
  <keyword>repetitive transcranial magnetic stimulation</keyword>
  <keyword>low frequency</keyword>
  <keyword>frontal lobe epilepsy</keyword>
  <keyword>brain excitability</keyword>
  <keyword>electromyography</keyword>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epilepsy, Frontal Lobe</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
